179 related articles for article (PubMed ID: 24131613)
1. Counting the costs of cancer care.
Lyman GH
Lancet Oncol; 2013 Nov; 14(12):1142-3. PubMed ID: 24131613
[No Abstract] [Full Text] [Related]
2. Economic burden of cancer across the European Union: a population-based cost analysis.
Luengo-Fernandez R; Leal J; Gray A; Sullivan R
Lancet Oncol; 2013 Nov; 14(12):1165-74. PubMed ID: 24131614
[TBL] [Abstract][Full Text] [Related]
3. Cancer in Botswana: resources and opportunities.
Suneja G; Ramogola-Masire D; Medhin HG; Dryden-Peterson S; Bekelman JE
Lancet Oncol; 2013 Jul; 14(8):e290-1. PubMed ID: 23816293
[No Abstract] [Full Text] [Related]
4. The war on cancer: progress at what price?
Konski A
J Clin Oncol; 2011 Apr; 29(12):1503-4. PubMed ID: 21402613
[No Abstract] [Full Text] [Related]
5. Economic Burden of Bladder Cancer Across the European Union.
Leal J; Luengo-Fernandez R; Sullivan R; Witjes JA
Eur Urol; 2016 Mar; 69(3):438-47. PubMed ID: 26508308
[TBL] [Abstract][Full Text] [Related]
6. User beware: we need more science and less art when measuring financial toxicity in oncology.
de Souza JA; Yap B; Ratain MJ; Daugherty C
J Clin Oncol; 2015 Apr; 33(12):1414-5. PubMed ID: 25732158
[No Abstract] [Full Text] [Related]
7. Reporting and grading financial toxicity.
Khera N
J Clin Oncol; 2014 Oct; 32(29):3337-8. PubMed ID: 25199760
[No Abstract] [Full Text] [Related]
8. Value in Oncology: Balance Between Quality and Cost.
Raghavan D; Legnini MW
Am Soc Clin Oncol Educ Book; 2016; 35():9-13. PubMed ID: 27249680
[No Abstract] [Full Text] [Related]
9. Reply to J.A. de Souza et al.
Khera N
J Clin Oncol; 2015 Apr; 33(12):1415-6. PubMed ID: 25732169
[No Abstract] [Full Text] [Related]
10. The cost of treating cancer patients: treatments versus reimbursements.
Goldstein MG
Md Med; 2011; 12(4):15. PubMed ID: 22455202
[No Abstract] [Full Text] [Related]
11. [Methodology of economic assessment: example in oncology].
Jaisson-Hot I; Schott AM; Clippe C; Ganne C; Hajri T; Poncet B; Trillet-Lenoir V; Colin C
Bull Cancer; 2003 Nov; 90(11):939-45. PubMed ID: 14706896
[TBL] [Abstract][Full Text] [Related]
12. Key factors impacting the delivery and financing of oncology care in the United States.
Goldsmith PJ; Paivanas T
J Natl Compr Canc Netw; 2006 May; 4(5):434-7. PubMed ID: 16715607
[No Abstract] [Full Text] [Related]
13. Is high and growing spending on cancer treatment and prevention harmful to the United States economy?
Pauly MV
J Clin Oncol; 2007 Jan; 25(2):171-4. PubMed ID: 17210935
[No Abstract] [Full Text] [Related]
14. The Urgent Need in Oncology for a Comprehensive Cost of Care Task Force.
Palmer JD; Patel TT; Fisher SA
JAMA Oncol; 2018 Aug; 4(8):1045-1046. PubMed ID: 29931129
[No Abstract] [Full Text] [Related]
15. Can we afford the war on cancer?
Szucs TD
Onkologie; 2008 Mar; 31(3):81. PubMed ID: 18322408
[No Abstract] [Full Text] [Related]
16. Not at any cost: organizations help patients cope with costs of cancer care.
Printz C
Cancer; 2011 Mar; 117(5):879. PubMed ID: 21351079
[No Abstract] [Full Text] [Related]
17. [Economy and medicine in haematology and oncology].
Krych M; Ostermann H
Dtsch Med Wochenschr; 2008 Oct; 133(41):2115-8. PubMed ID: 18985566
[No Abstract] [Full Text] [Related]
18. Changes in European cross-border cancer research and treatment.
Gethins M
J Natl Cancer Inst; 2011 Jun; 103(11):845-6, 852. PubMed ID: 21606437
[No Abstract] [Full Text] [Related]
19. Enlightened oncologists can provide quality cancer care at reduced costs.
Devi CR
J Surg Oncol; 2014 Nov; 110(6):643-4. PubMed ID: 25125148
[No Abstract] [Full Text] [Related]
20. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
[No Abstract] [Full Text] [Related]
[Next] [New Search]
